A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arpit Rao, MD
Baylor College of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
414 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Kaiser Permanente Downtown Commons
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Sharp Memorial Hospital
San Diego, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Kaiser Permanente San Leandro
San Leandro, California, United States
- Pacific Central Coast Health Center-San Luis Obispo
San Luis Obispo, California, United States
- Kaiser San Rafael-Gallinas
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Mission Hope Medical Oncology - Santa Maria
Santa Maria, California, United States
- Kaiser Permanente-Santa Rosa
Santa Rosa, California, United States
- Kaiser Permanente-South San Francisco
South San Francisco, California, United States
- Saint Helena Hospital
St. Helena, California, United States
- Kaiser Permanente-Stockton
Stockton, California, United States
- Kaiser Permanente Medical Center-Vacaville
Vacaville, California, United States
- Northbay Cancer Center
Vacaville, California, United States
- Kaiser Permanente-Vallejo
Vallejo, California, United States
- Kaiser Permanente-Walnut Creek
Walnut Creek, California, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Rocky Mountain Cancer Centers-Penrose
Colorado Springs, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Oct 2021
- Primary completion
- 15 Mar 2027
- Completion
- 30 Sept 2027
- Last update posted
- 5 Feb 2026
- Registered enrollment
- 61
- Registry id
- NCT04455750
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.